|
|
Research on rating of prognostic factors in children immune thrombocytopenia |
YANG Menglu, SUN Weimei, LI Xiaohua, LI Jianchang* |
Department of Pediatrics,Binzhou Medical University Hospital,Binzhou 256603, Shandong,P.R.China |
|
|
Abstract Objective To investigate the factors affecting the prognosis of children immune thrombocytopenia,and to establish a clinical scoring system for the prognosis of children immune thrombocytopenia.Methods (1)Data of 206 children with immune thrombocytopenic treated in our hospital from March 2016 to February 2019 were statistically analyzed.Gender,age,i-nitial platelet count,bleeding,infection,and therapeutic effect were recorded,respectively.Moreover,the number of megakaryocytes of 103 children who underwent bone marrow biopsy were recorded.(2)Outpatient and telephone follow-up were conducted for the children.(3)To make univariate and multivariate Logistic regression analysis on the prognostic factors.(4)To assign reasonable scores to risk factors and to calculate the relationship between score and prognosis.Results Among 206 cases with immune thrombocytopenic,170 cases had a good prognosis and 36 had a poor prognosis;among the 103 cases who underwent bone marrow biopsy,76 cases had good prognosis and 27 cases had poor prognosis.The results of statistical analysis showed that there were statistically significant differences in age,prodromal infection,bleeding,initial platelet count and initial Megakaryocyte count,without statistically significant differences in gender or treatment.In the multivariate Logistic regression analysis,the independent risk factors affecting prognosis were age,bleeding,prodromal infection,initial platelet count and initial Megakaryocyte count.The above factors were assigned and the total score was calculated.The results showed that the lower the score was,the better the prognosis was.Conclusion Age,bleeding,prodromal infection,initial platelet count and initial Megakaryocyte count have important predictive significance for the prognosis of immune thrombocytopenia and can be used to guide the treatment.
|
Received: 25 December 2019
|
|
|
|
|
[1] 中华医学会儿科学分会血液学组,《中华儿科杂志》编辑委员会.儿童原发性免疫性血小板减少症诊疗建议[J].中华儿科杂志,2013,51(5):382-384. [2] 马洁,吴润晖.儿童免疫性血小板减少症的自然病程及临床预后影响因素[J].中国小儿血液与肿瘤杂志,2013,18(1):43-46. [3] CONTRERAS R J,OPARIL S.Sex difference in blood pressure of spontaneously hypertensive rats influenced by perinatal NaCl exposure[J].Physiology &Behavior,1992,51(3):449-455. [4] 李婉丽,郑敏翠,宋国才,等.儿童特发性血小板减少性紫癜预后影响因素分析[J].中国新医药,2004,3(4):46-47. [5] JUNG J Y,O A R,KIM J K,et al.Clinical course and prognostic factors of childhood immune thrombocytopenia:single center experience of 10 years[J].Korean Journal of Pediatrics,2016,59(8):335-340. [6] 葛均波,徐永健.内科学[M].8版.北京:人民卫生出版社,2014:625-626. [7] 胡亚美.诸福棠实用儿科学[M].8版.北京:人民卫生出版社,2015:1898-1899. [8] JAYABOSE S,LEVENDOGLU-TUGAL O,OZKAYNKAK M F,et al.Long-Term Outcome of Chronic Idiopathic Thrombocytopenic Purpura in Children[J].Journal of Pediatric Hematology/Oncology,2004,26(11):724-726. [9] WATTS,R G.Idiopathic Thrombocytopenic Purpura:A 10-Year Natural History Study at the Childrens Hospital of Alabama[J].Clinical Pediatrics,2004,43(8):691-702. [10] 马广伟,岳智慧,孙良忠,等.特发性血小板减少性紫癜预后因素分析[J].广东医学,2001,22(12):135-136. [11] AHMED S,SIDDIQUI A K,SHAHID R K,et al.Prognostic variables in newly diagnosed childhood immune thrombocytopenia[J].American journal of hematology,2004,77(4):358-362. [12] 罗春华.特发性血小板减少性紫癜的发病机理及诊治进展[J].中国实用儿科杂志,1992,53(5):232-233. [13] 陈陶,李帆帆,章赵华,等.儿童免疫性血小板减少性紫癜的预后因素分析[J].中华全科医学,2017,15(4):620-622. [14] 陈美仙,卢俏春.ITP血小板计数与骨髓巨核细胞数及分类关系研究[J].中国妇幼健康研究,2017,28(S1):493-494. [15] 陈莹.小儿特发性血小板减少性紫癜骨髓巨核细胞数的相关性分析[J].中国社区医师(医学专业),2013,15(10):102-103. [16] 武国霞,韩静,韩洁,等.小儿特发性血小板减少性紫癜急性至慢性的危险因素分析[J].临床儿科杂志,2008,26(9):792-795. |
[1] |
DU Chunjuan, GUO Fengli, HAN Xia, LI Mianli, WANG Feng, NING Fangling, HAO Yanzhang, CHEN Shaoshui, YUAN Haibin. Effect of apatinib mesylate tablets in the third-line treatment of extensive-stage small cell lung cancer[J]. 滨州医学院学报, 2020, 43(5): 330-332. |
[2] |
DU Chunjuan, GUO Fengli, HAN Xia, LI Mianli, WANG Feng, NING Fangling, HAO Yanzhang, CHEN Shaoshui, YUAN Haibin. Effect of apatinib mesylate tablets in the third-line treatment of extensive-stage small cell lung cancer[J]. 滨州医学院学报, 2020, 43(5): 330-332. |
[3] |
SHAO Zhiying, SUNLinlin, LI Xiaodan, SUN Rongling, SHI Jun. Analysis of laboratory indicators predicting the risk of death for severe fever with thrombocytopenia syndrome[J]. 滨州医学院学报, 2020, 43(5): 340-343. |
[4] |
WANG Chunyan, ZHANG Yuanyuan, GAO Xinxin, DU Meimei, WANG Qingshan. Role of behavior management in dental treatment of preschool children with tooth decay[J]. 滨州医学院学报, 2020, 43(3): 209-211. |
[5] |
. [J]. 滨州医学院学报, 2019, 42(6): 479-480. |
[6] |
. [J]. 滨州医学院学报, 2019, 42(5): 398-398. |
|
|
|
|